Log In
Print
BCIQ
Print
Print this Print this
 

FX125L

  Manage Alerts
Collapse Summary General Information
Company Funxional Therapeutics Ltd.
DescriptionOral small molecule somatostatin receptor 2 (SSTR2) agonist
Molecular Target Somatostatin receptor 2 (SSTR2)
Mechanism of Action 
Latest Stage of DevelopmentPhase II
IndicationInflammation
Partner

Boehringer Ingelheim GmbH
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today